How to Check Nephrocare Health Services IPO Allotment Status

Nephrocare Health Services Ltd. provides end-to-end dialysis care through a wide network of clinics across India and select international markets. The company was incorporated in 2010. It offers services including diagnosis, haemodialysis, home and mobile dialysis, and wellness programs, supported by an in-house pharmacy.

Nephrocare has formed strategic partnerships with established hospital chains such as Max Super Speciality Hospital, Fortis Escorts Hospitals, Care Hospitals, Wockhardt Hospitals, Paras Healthcare, The Calcutta Medical Research Institute, Jehangir Hospital, and Ruby Hall Clinic to operate in-house dialysis centers. As of September 30, 2025, Nephrocare Health had total assets of ₹1,193.68 crore.

The Nephrocare Health IPO came with a total issue size of ₹871.05 crore, comprising a fresh issue of ₹353.40 crore and an offer for sale of ₹517.64 crore. The IPO opened on December 10, 2025, and closed on December 12, 2025. The allotment is expected on Monday, December 15, 2025. The share price band was set at ₹438 to ₹460 per share.

Don’t Miss Out on the Next Big IPO – Invest With Just a Few Clicks!

Open Account Now

Steps to Check Nephrocare Health Services IPO Allotment Status on Registrar Site

• Visit the Kfin Technologies Ltd. 
• Select "Nephrocare Health Services" from the dropdown menu on the allotment status page
• Enter your PAN ID, Demat Account Number, or Application Number in the designated field
• Complete the captcha verification process and click on the "Submit" button to view your allotment status

Steps to Check Nephrocare Health Services IPO Allotment Status on BSE

• Navigate to the BSE IPO Allotment Status Page
• Select the issue type: equity/debt
• Choose "Nephrocare Health Services" from the list of active IPOs in the dropdown menu
• Input your Application Number and PAN ID in the required fields
• Verify the captcha and click "Search" to check your allotment status

Nephrocare Health IPO Subscription Status

Nephrocare Health IPO received strong investor interest, being subscribed 14.06 times overall. Here is the category-wise breakdown as of 4:54:35 PM on December 12, 2025:

• QIB Category (Ex Anchor): 26.82 times
• Non-Institutional Investors (NII): 24.75 times
• Retail Investors: 2.33 times
• Employees: 2.80 times

Nephrocare Health IPO Share Price and Investment Details

The minimum investment required was ₹14,720 for 1 lot (32 shares). The issue raised ₹260.26 crore from anchor investors and included 83,532 shares reserved for employees at a discount of ₹41.00.

Given the strong overall subscription of 14.06 times, with robust institutional participation at 26.82 times, strong NII interest at 24.75 times, and moderate retail subscription at 2.33 times, the IPO is expected to list at a premium.

Utilisation of IPO Proceeds

The proceeds will be utilised for capital expenditure for opening new dialysis clinics in India amounting to ₹129.11 crore, pre-payment or scheduled repayment of certain borrowings aggregating ₹136.00 crore, and for general corporate purposes.

Business Overview

Nephrocare Health Services Limited is engaged in offering comprehensive dialysis care globally. It is the largest dialysis provider in Asia and the fifth-largest globally. The company has shown consistent growth in both revenue and profitability across reported periods.

The company benefits from being India’s and Asia’s largest dialysis chain, supported by leadership across markets, scale-driven cost efficiencies through an asset-light model, clinical excellence backed by advanced technology and standardized protocols, organic growth complemented by successful acquisitions, and a seasoned management team backed by marquee investors. However, investors should note the post-issue P/E ratio of 162.19 and Price to Book Value of 7.72.